Aclaris Therapeutics, Inc. Ratios

Ratios Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 28.28%52.69%4.07%20.81%30.29%86.48%89.05%85.09%
EBT Margin -4,180.21%-1,334.81%-2,686.11%-791.98%-1,343.96%-292.11%-284.32%-705.48%
EBIT Margin -3,230.01%-1,378.31%-2,627.35%-785.44%-1,327.07%-302.01%-311.55%-758.18%
EBITDA Margin -4,070.11%-2,155.11%-3,817.15%-787.46%-1,345.88%-294.37%-280.62%-704.39%
Operating Margin -3,230.01%-1,378.31%-2,627.35%-785.44%-1,327.07%-302.01%-311.55%-758.18%
Net Margin -4,071.48%-823.18%-1,131.11%2.14%-1,343.96%-292.11%-283.15%-705.48%
FCF Margin -3,321.33%-1,660.98%-2,319.80%-602.99%-775.65%-229.13%-254.84%-107.88%
Efficiency
Assets Average 259.54M186.93M84.54M161.00M252.90M226.00M208.87M
Equity Average 220.19M142.52M53.78M117.50M197.48M177.40M156.37M
Invested Capital 225.85M245.04M69.91M48.30M197.34M197.62M157.18M155.55M
Asset Utilization Ratio 0.020.020.080.040.120.140.09
Leverage & Solvency
Debt to Equity 0.00
Debt Ratio 0.00
Equity Ratio 0.930.780.710.530.790.780.800.71
Valuation
Enterprise Value 543.04M581.69M566.53M134.55M3.21M223.56M698.83M832.69M-44.73M63.55M
Market Capitalization 543.04M581.69M760.38M302.52M78.22M277.69M890.25M1,050.26M74.38M177.15M
Return Ratios
Return on Sales -10.73%-8.23%-11.31%0.02%-13.44%-2.92%-2.83%-7.05%
Return on Capital Employed -0.37%-0.68%-0.73%-0.65%-0.39%-0.50%-0.80%
Return on Invested Capital -0.86%-0.55%
Return on Assets -0.20%-0.26%0.00%-0.56%-0.34%-0.39%-0.63%
Return on Equity -0.23%-0.34%0.00%-0.77%-0.44%-0.50%-0.84%